Melior Discovery
is a contract research provider of phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services... Read moreMelior Discovery
is a contract research provider of phenotypic screening, in vivo pharmacology, drug abuse liability and seizure potential services... Read more
News
Mar 19, 2024
Business Wire
Melior Discovery: Melior Is Recognized as CRO of the Year by Life Sciences Review
Jun 22, 2023
Business Wire
Press Release: Melior Discovery : Melior Is Selected as a Top 20 CRO by Pharma Tech Outlook
Apr 13, 2022
Citybizlist
Melior Discovery: Melior Announces Additions to Its Management and Scientific Team
Sep 28, 2020
PRWeb
Press Release: Melior Discovery : Visikol and Melior Discovery Partner on Precision Cut Liver Ex Vivo NASH Models
Jun 28, 2020
Pittsburgh Citybizlist
Melior Discovery: Melior Discovery Announces Partnership with SFA
Jun 24, 2020
BioSpace
Melior Discovery: Melior Discovery Announces Partnership with SFA on Grant Directed to COVID-19
Jan 16, 2017
BioPortfolio
Melior Discovery: Melior Discovery Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
May 09, 2016
Philly
Melior Discovery: Melior spins off Parkinson treatment
May 09, 2016
BioSpace
Melior Discovery: Melior Discovery Announces Spinout of Melior Pharmaceuticals
May 09, 2016
The Business Journals
Melior Discovery: New biopharm company formed to advance potential Parkinson's therapy
